Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Protean Select. This analysis is provided for institutional research purposes only and is not investment advice.
"Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish forestry giant Holmen."
Protean's January 2026 partner letter reports strong performance for FY 2025 across all four products, with Protean Select up 10.8% and Protean Small Cap up 20.7% (beating its benchmark by 13.4%). Total assets under management have grown to $600m USD. The letter features a detailed, multi-page deep-dive explaining the firm's structural short position in Swedish forestry company Holmen, citing high localized wood costs, South American eucalyptus competition, and climate-related harvesting issues. On the long side, the small-cap fund highlights its cornerstone participation in the Arctic Falls IPO and successful takeover bids for portfolio holdings Addvise and Nilfisk.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Growth Outlook
Market outlook remains moderate conviction: Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Risk Appetite
Risk appetite posture is moderate conviction: Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Forward Guidance
Forward guidance signal: Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Language Signal
Tone analysis indicates above average conviction language: Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Perceived Risk
Perceived risk level is evaluated as above average conviction. Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
Time Horizon
Investment time horizon reflects a above average conviction orientation. Protean concludes a highly successful 2025 with $600m USD in AUM, warns of potentially mediocre market years ahead, and lays out a compelling, structural short thesis on Swedish fo...
